Stay updated on Pyrotinib Effects After Trastuzumab in Early Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib Effects After Trastuzumab in Early Breast Cancer Clinical Trial page.

Latest updates to the Pyrotinib Effects After Trastuzumab in Early Breast Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA site-wide NIH notice explains the terminology transition from “Artificial Intelligence” to “Super Intelligence.” The displayed ClinicalTrials.gov revision changes from v3.7.1 to v3.7.2.SummaryDifference0.9%

- Check41 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry v3.7.0 was added to the record history, and the previous revision label v3.6.6 was removed, indicating an update to the site’s release notes in the history log.SummaryDifference0.1%

- Check76 days agoChange DetectedA new revision entry (v3.6.6) was added to the study's record history, and the previous revision (v3.6.5) was removed, reflecting an update to the record's documentation.SummaryDifference0.1%

- Check90 days agoChange DetectedRecruitment status is updated to 'No longer looking for participants.' The version history now adds sections for Study Design and Study Status, and removes prior sponsor and verification metadata.SummaryDifference1%

Stay in the know with updates to Pyrotinib Effects After Trastuzumab in Early Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib Effects After Trastuzumab in Early Breast Cancer Clinical Trial page.